VKTX
Viking Therapeutics, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares -5.9% ·
flujo de acciones -6.2% ·
nuevas posiciones netas -12.5%
· fórmula
Distribución amplia: acciones en descenso y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 24.17K | $674,494 | n/a | −1 |
| Q2 2026 | 108 | +6 | 57.61M | $2.25B | +9 | −4 |
| Q1 2026 | 106 | -1 | 56.45M | $1.88B | +7 | −8 |
| Q4 2025 | 106 | +1 | 58.95M | $2.07B | +2 | −1 |
| Q3 2025 | 16 | -1 | 41.62M | $1.09B | +2 | −4 |
| Q2 2025 | 15 | 0 | 36.99M | $980.19M | +2 | −2 |
| Q1 2025 | 12 | +3 | 10.64M | $256.98M | +3 | n/a |
| Q4 2024 | 9 | -3 | 10.39M | $418.15M | n/a | −3 |
| Q3 2024 | 11 | -1 | 6.74M | $426.33M | n/a | −1 |
| Q2 2024 | 12 | n/a | 5.57M | $295.04M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasivo) | 10.00M | -1.6% | $262.78M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | Fidelity (FMR) ✦ | 5.79M | -41.0% | $152.16M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 3 | BlackRock ✦ (pasivo) | 5.60M | +2.9% | $147.07M | 0.0% | ▲ Add | 2 | SEC ↗ ×18 |
| 4 | JPMorgan Chase ✦ | 5.15M | n/a | $135.45M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 5 | State Street Global Advisors ✦ (pasivo) | 4.51M | +19.6% | $118.62M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 3.73M | n/a | $98.00M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 7 | Two Sigma Investments ✦ | 2.09M | +58.7% | $54.81M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 1.90M | +117.5% | $49.89M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Geode Capital Management ✦ (pasivo) | 1.61M | -16.4% | $42.28M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 10 | Millennium Management ✦ | 427.69K | -54.6% | $11.24M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 11 | Goldman Sachs Group ✦ | 267.74K | n/a | $7.04M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | Gotham Asset Management ✦ | 169.68K | Nuevo | $4.46M | 0.0% | New | 1 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 161.36K | -21.5% | $4.24M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 123.49K | Nuevo | $3.25M | 0.0% | New | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 85.49K | +9.3% | $2.25M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 16 | AQR Capital Management ✦ | 13.07K | -79.8% | $334,386 | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Gotham Asset Management | $4.46M | 0.0% |
| Bridgewater Associates | $3.25M | 0.0% |
Posición cerrada
| Norges Bank | $46.85M | era 0.0% |
| Duquesne Family Office | $14.56M | era 0.4% |
| Point72 Asset Management | $1.06M | era 0.0% |
| Renaissance Technologies | $866,550 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 9.80K acciones, $318 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.